Thrombin is a vital enzyme in the blood coagulation ... Additionally, studies have explored the binding modes of prothrombin cleavage site sequences to the factor Xa catalytic triad, revealing ...

Four years ago, protein drug developer Zymogenetics in Seattle began developing a recombinant version of the blood-clotting protein thrombin. On 17 January, it received US marketing approval for ...